Product Images Desvenlafaxine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Desvenlafaxine NDC 50090-5293 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 2 - desvenlafaxine figure2
![desvenlafaxine-figure2.jpg Figure 2 - desvenlafaxine figure2](https://ndclist.com/assets/spl/images/88ac1206-864b-47a3-82ab-be83bc9532f3/400x-desvenlafaxine-figure2.jpg)
Change due to PK (Geometric mean ratio (30% Cl): This text appears to be related to pharmacokinetics (PK) and the effect of CYP3A4 inhibitors on drug metabolism. It mentions ketoconazole as an example. The text also includes information about changes in the Cmax (maximum concentration) and AUC (area under the curve) values, expressed as geometric mean ratios with confidence intervals (30% Cl). It seems to be discussing the change in pharmacokinetic parameters relative to a reference.*
Figure 4 - desvenlafaxine image4
![desvenlafaxine-image4.jpg Figure 4 - desvenlafaxine image4](https://ndclist.com/assets/spl/images/88ac1206-864b-47a3-82ab-be83bc9532f3/400x-desvenlafaxine-image4.jpg)
Estimated proportion of patients with relapse (%): 10. Time to relapse (days from randomization): Desvenlafarine Extended-Release Tablets 50mg - Placebo. Maximum value on the graph: 200.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.